Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Kidney transplantation using alemtuzumab, belatacept, and sirolimus: Five-year follow-up
Robin Schmitz, Zachary W. Fitch, He Xu, et al.
American Journal of Transplantation (2020) Vol. 20, Iss. 12, pp. 3609-3619
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy
María José Mansilla, Silvia Presas‐Rodríguez, Aina Teniente‐Serra, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 6, pp. 1353-1374
Open Access | Times Cited: 41
Costimulatory Blockade and Solid Organ Transplantation: The Past, Present, and Future
William H. Kitchens, Christian P. Larsen, I. Raul Badell
Kidney International Reports (2023) Vol. 8, Iss. 12, pp. 2529-2545
Open Access | Times Cited: 12
Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients
Allan D. Kirk, Andrew Adams, Antoine Dürrbach, et al.
American Journal of Transplantation (2020) Vol. 21, Iss. 5, pp. 1691-1698
Open Access | Times Cited: 27
IFI16-STING-NF-κB signaling controls exogenous mitochondrion-induced endothelial activation
Shu Li, He Xu, Mingqing Song, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 6, pp. 1578-1592
Open Access | Times Cited: 10
Targeting inflammation and immune activation to improve CTLA4-Ig-based modulation of transplant rejection
Marcos Iglesias, Daniel C. Brennan, Christian P. Larsen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Modulating the wayward T cell: New horizons with immune checkpoint inhibitor treatments in autoimmunity, transplant, and cancer
Leonard H. Calabrese, Roberto Caporali, Christian U. Blank, et al.
Journal of Autoimmunity (2020) Vol. 115, pp. 102546-102546
Open Access | Times Cited: 14
Functional Characteristics and Phenotypic Plasticity of CD57+PD1− CD4 T Cells and Their Relationship with Transplant Immunosuppression
Brian I. Shaw, Jaclyn R. Espinosa, Linda Stempora, et al.
The Journal of Immunology (2021) Vol. 206, Iss. 7, pp. 1668-1676
Open Access | Times Cited: 11
Xenorecognition and costimulation of porcine endothelium-derived extracellular vesicles in initiating human porcine-specific T cell immune responses
S. Li, Imran J. Anwar, Aidan J. Canning, et al.
American Journal of Transplantation (2023) Vol. 23, Iss. 7, pp. 904-919
Open Access | Times Cited: 4
Open letter to Bristol Myers Squibb: Belatacept; we aren’t done yet
Flavio Vincenti, Klemens Budde, Josep M. Grinyó, et al.
American Journal of Transplantation (2023) Vol. 23, Iss. 10, pp. 1483-1484
Closed Access | Times Cited: 4
The Conversion From Mycophenolic Acid to Mammalian Target of Rapamycin Inhibitor Reduces the Incidence of Cytomegalovirus Replication in Belatacept-Treated Kidney-Transplant Recipients
Arnaud Del Bello, Joseph Cachoux, Florence Abravanel, et al.
Kidney International Reports (2024) Vol. 9, Iss. 6, pp. 1912-1915
Open Access | Times Cited: 1
Immunomodulation of T cell-mediated Alloimmunity by Proximity to Endothelial Cells under mTOR Blockade
Shu Li, Liuyang Wang, Victoria A. Bendersky, et al.
American Journal of Transplantation (2024)
Closed Access | Times Cited: 1
Regulatory T cells and transplantation tolerance: Emerging from the darkness?
Herman Waldmann
European Journal of Immunology (2021) Vol. 51, Iss. 7, pp. 1580-1591
Open Access | Times Cited: 10
Use of belatacept in kidney transplantation: what's new?
Idris Yakubu, Irfan Moinuddin, Gaurav Gupta
Current Opinion in Organ Transplantation (2022) Vol. 28, Iss. 1, pp. 36-45
Closed Access | Times Cited: 7
Optimal Immunosuppression Strategy in the Sensitized Kidney Transplant Recipient
Danae Olaso, Miriam Manook, Demetrios Moris, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 16, pp. 3656-3656
Open Access | Times Cited: 9
Belatacept-Based Maintenance Immunosuppression Controls the Post-Transplant Humoral Immune Response in Highly Sensitized Nonhuman Primates
Robin Schmitz, Zachary W. Fitch, Miriam Manook, et al.
Kidney360 (2022) Vol. 3, Iss. 12, pp. 2116-2130
Open Access | Times Cited: 6
Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression
V. Ram Peddi, Bradley Marder, Luis Gaite, et al.
Transplantation Direct (2023) Vol. 9, Iss. 2, pp. e1419-e1419
Open Access | Times Cited: 2
Induction of donor-specific tolerance to heart transplantation: From concept to clinical translation
Lillian Kang, M. Louise Markert, Joseph W. Turek
Journal of Thoracic and Cardiovascular Surgery (2022) Vol. 165, Iss. 5, pp. 1661-1666
Closed Access | Times Cited: 4
Modulation of Xenogeneic T-cell Proliferation by B7 and mTOR Blockade of T Cells and Porcine Endothelial Cells
S. Li, He Xu, Allan D. Kirk
Transplantation (2021) Vol. 106, Iss. 5, pp. 950-962
Open Access | Times Cited: 5
Kidney transplantation: the recipient

Elsevier eBooks (2024), pp. 411-691
Closed Access
New immunosuppressive protocols in living donor organ transplantation
Stuart J. Knechtle, Robin Schmitz
Elsevier eBooks (2024), pp. 1443-1447
Closed Access
Cellular Therapies in Solid Organ Allotransplantation: Promise and Pitfalls
Brian I. Shaw, Jeffrey R. Ord, Chloe K. Nobuhara, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 3
Outcomes after anti-thymocyte globulin vs Basiliximab induction before deceased donor kidney transplants
Muhammad Saad Hafeez, Muneeb Ul Haq, Syed Shahyan Bakhthiyar, et al.
Transplant Immunology (2022) Vol. 75, pp. 101733-101733
Closed Access | Times Cited: 1
Age-related effects on thymic output and homeostatic T cell expansion following depletional induction in renal transplant recipients
He Xu, Hui‐Jie Lee, Robin Schmitz, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 9, pp. 3163-3174
Open Access | Times Cited: 1
Quantifying spillover benefits in value assessment: a case study of increased graft survival on the US kidney transplant waitlist
Syvart Dennen, O. Espinosa, Kelly Birch, et al.
Journal of Medical Economics (2021) Vol. 24, Iss. 1, pp. 918-928
Open Access | Times Cited: 1
Induction Therapy in Pediatric Renal Transplant Recipients
Olga Charnaya, Asha Moudgil, Dechu Puliyanda
(2023), pp. 109-131
Closed Access
Page 1 - Next Page

Scroll to top